Learning from practice: compulsory licensing cases and access to medicines

Finding flaws: the limitations of compulsory licensing for improving access to medicines--an international comparison.

Compulsory Licensing and Access to Medicine in Developing Countries

Out-licensing: a practical approach for improvement of access to medicines in poor countries.

VIEWPOINT There is much disagreement between the pharmaceutical industry and advocacy groups about how to provide patented medicines in poor countries. While everyone agrees that access to medicines in developing countries should be improved, too often this shared sensibility is submerged by an excess of timid incrementalism by industry, and demagoguery by activists. Neither contribution is con...

Compulsory licensing of technology and the essential facilities doctrine

We look at compulsory licensing of intellectual property as remedy for anti-competitive practice. We identify aspects of intellectual property that warrants a different remedy from those using general definitions and remedies for essential facility. Based on the analysis, we present a characterisation of optimal compulsory licensing for a simple market. ∗Department of Economics, University of A...

Compulsory patent licensing and local drug manufacturing capacity in Africa.

Africa has the highest disease burden in the world and continues to depend on pharmaceutical imports to meet public health needs. As Asian manufacturers of generic medicines begin to operate under a more protectionist intellectual property regime, their ability to manufacture medicines at prices that are affordable to poorer countries is becoming more circumscribed. The Doha Declaration on the ...